ILMN Fair Value — Illumina Inc

Life Sciences Tools · Institutional-depth multi-model valuation on Equity Rank

Current Price
$190.45
Consensus Fair Value
$131.83
Margin of Safety
-30.8%

When does ILMN report earnings?

Illumina Inc (ILMN) is next scheduled to report earnings on Jul 30, 2026. The consensus analyst EPS estimate for the upcoming quarter is $1.24.

Heading into this report, the model's fair value estimate sits 30.8% below the current price (model fair value differential below current price). Descriptive context only — not a forecast of the earnings result.

Earnings dates and estimates are sourced from third-party data and may change or lag. Informational only.

How ILMN's valuation models agree

Equity Rank computed model fair value for ILMN from 9 independent valuation methods with sufficient data. 1 place fair value above the current price of $190.45, and 8 place it below. The model-blended estimate lands at $131.83 — a model fair value differential of 30.8% below the current price under these model assumptions. The larger group places fair value below the current price.

Models: FV above price
1
Models: FV below price
8
Models compared
9

Each method (DCF, Graham Number, EPV, Three-Stage DCF, DDM, Residual Income, Justified Price-to-Book, and more) is weighted by historical sector accuracy. Model-derived and informational only — not investment advice.

ILMN fundamental profile

Equity Rank's fundamental strength composite scores ILMN at 76.3/100 (A-, Strong), blending profitability, balance-sheet, and cash-flow quality. Over the trailing three years, free cash flow has compounded at +106.3% per year and gross margin has moved +1.9 pp. Its SAVE composite score has moved -0.8 over the past 30 days.

A composite quality metric for research context — not a rating, recommendation, or directional signal.

About ILMN

Illumina Inc (ILMN) is analyzed on Equity Rank using the S·A·V·E framework: Sentiment, Analyst consensus, Valuation (DCF, Graham, multiples), and Earnings quality. The consensus fair value is a blend of multiple models designed to surface potential mispricings versus current market price.

Equity Rank provides institutional-depth valuation research on 3,000+ US equities. Data is refreshed daily and combines quantitative models with AI-driven qualitative analysis.

Related Stocks in Life Sciences Tools

JNJ · UNH · PFE · ABBV · MRK

Research Tools

Intrinsic Value Calculator · DCF Calculator · Margin of Safety Calculator